ANRI
Venture capitalTokyo · Pre-Seed–Growth · 4 people tracked
Also known as ANRI株式会社
Investment thesis
Seed-stage, high-maintenance investor that targets ~10% at seed (aiming ~25% at exit), aggressively backing university-origin deep-tech and helping founders with legal, IP, team, PR, and marketing.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from public directories
What they invest in
from 10 of 10 portfolio companiesBiotech ×4SaaS ×3AI & Machine Learning ×2Deep Tech ×2FoodTech ×2Healthtech ×2AgTech ×1B2B Marketplaces ×1
HQs:Japan×8United States×1
Investments · 10 tracked
founders shown can be your intro pathChompy builds a food delivery service and offers a free service (beta) that lets restaurants and food retail brands create their own official app and website.
FoodTechMarketplacesSaaSTokyo, JP
大見 周平(代表取締役)Tatsuya Yagi(Founder)in八木 達也(取締役CTO)
Co-investorsCoral CapitalDelight VenturesDCM VenturesGreenoaksW Inc.
Cosomil develops single-molecule enzyme activity measurement technology for early disease diagnosis and drug development support in healthcare.
BiotechDeep TechDigital HealthHealthtechMedical DevicesTokyo, JP
鏡味 優(Representative Director (CEO))坂本 眞伍(Chief Technology Officer)
Co-investorsCoral CapitalDelight Ventures
Jamm is a Tokyo-based fintech company building a payment product for Japan's market, focused on secure authentication, low fees by removing intermediaries, and payments made without lending to users.
FintechTokyo, JP
橋爪 捷(代表取締役 (CEO))
Co-investorsDG Daiwa VenturesXTech VenturesCoreline Ventures
Morus Inc. is a Japanese company established in April 2021 and led by CEO Ryo Sato.
AgTechBiotechFoodTechSector AgnosticWellness & Fitness
Kunihiro Shiomi(Co-founder (Professor, Shinshu University))Ryo Sato(CEO)in
Co-investorsDG Daiwa VenturesGlobisHachijuni CapitalMizuho CapitalSamurai IncubateSMBC Venture Capital+1 more
Myrodia Therapeutics is a Japanese biopharmaceutical company developing drug candidates based on its "sensory drug discovery" concept, which uses sensory stimuli to induce artificial hibernation and protective physiological states.
BiotechDeep TechHealthtech
小早川 高(CSO / Founder)小早川 令子(Founder)神谷 勇輝(CEO / 代表取締役)水野 敦之(CFO)小林 実(COO)
Co-investorsRemiges Ventures, Inc.RDiscovery
SPeak provides a career platform for young international talent seeking employment in Japan, and an HR tech solution for companies recruiting global workers.
B2B MarketplacesEdTechHR TechTokyo, JP
Hiromi Karahashi(CEO)
Co-investorsEast VenturesGlobal BrainKDDI Open Innovation FundLifetime Ventures
Citadel AI is a platform for evaluating and monitoring various AI systems including large language models, image AI, and tabular AI.
AI & Machine LearningEnterprise SoftwareTokyo, JP
Kenny Song(Founder)in
Co-investorsTechstarsUTokyo Innovation Platform Co. Ltd.Coral CapitalMitsubishi UFJ CapitalSuntory Holdings Limited
AI & Machine LearningMarketing TechMedia & EntertainmentSaaS
Co-investorsAspenwoodHummer Winblad Venture Partners (HWVP)DG Daiwa VenturesHummer Winblad Venture PartnersXTech Ventures
Luup operates an electric micro-mobility sharing service providing electric kick scooters and pedal-assist bicycles for short urban trips in Japan.
ConsumerMobility & TransportationSaaSTokyo, JP
Co-investorsDG IncubationGlobal Braini-nest capitalOpen Network LabPKSHA Technology CapitalTBS Innovation Partners+2 more
Develops programmable mRNA therapies that last longer and target cells more precisely for cancer and other diseases.
BiotechBoston, US
Ala Alenazi(Director)Tasuku Kitada(Executive Officer, Director, Promoter)Samta Kundu(Executive Officer)Jacob Becraft(Executive Officer, Director, Promoter)
BoardJeb Keiper(Director)Pegah Ebrahimi(Director)
Co-investorsJIC Venture Growth InvestmentsKinnevikPlayground GlobalAmgen VenturesFPVICONIQ+2 more
Exits · 1
IPOs and acquisitions across the tracked portfolioJammacq. by Hopin
Portfolio news
latest coverage across their companiesLUUP · japanstartupobserver.substack.com · Dec 5, 2025
Jamm · fintechobserver.com · Jun 30, 2025
Frequently asked questions
- What stage does ANRI invest at?
- ANRI invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What is ANRI's typical check size?
- ANRI typically writes checks of $497K – $78M.
- What sectors does ANRI focus on?
- ANRI focuses on Crypto & Web3, Healthtech, SaaS, Sector Agnostic.
- Where is ANRI located?
- ANRI is headquartered in Tokyo, JP.
- Does ANRI lead rounds?
- ANRI typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamImages
Co-investors · 2
Portage is a global fintech and financial services investment platform that partners with companies across all stages, providing flexible capital alongside a network of investors, commercial partners, advisors and value creation experts.
Z Venture Capital is a venture capital firm that invests in and supports innovative startups pursuing transformative societal change, drawing on the resources, expertise, and assets of the LY Corporation Group.
Firms observed investing alongside ANRI, from public investor directories. Shared companies are the overlap with ANRI's recorded portfolio.
Similar investors
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Spark Capital is a venture capital firm that partners with founders, known for early investments including leading Twitter's Series B in 2008.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.